CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 50 enrolled
Drug / intervention
Sugar Pill +1 moredrug
Likely dose
Sugar Pill 145 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02158273
NCT02158273Phase 2Completed
CompareCT.gov

Medication Development in Alcoholism: Investigating PPAR Agonists

The Scripps Research Institute·interventional·Posted Jun 6, 2014·Updated Jun 2, 2017

In Brief

A Phase 2 clinical trial evaluating Sugar Pill and TRICOR (fenofibrate) for Alcoholism. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcoholism
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 6, 2014
Enrollment StartMay 1, 2014
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 12.1 years ago

Interventions

Sugar Pilldrug

145 mg/day, oral pill, 9 days

TRICOR (fenofibrate)drug

145 mg/day, oral pill, 9 days